Ecovyst Inc.

ECVT

CIK 0001708035 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$199M
↑+34.0% +$51Mvs FY2024 (Q4)
Operating Income
$22M
↓-2.8% -$631Kvs FY2024 (Q4)
Net Income
$5M
Gross Profit
$47M
↓-24.8% -$15Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
48/100
  • Profitability
    0ROIC 2.5% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 2.64 (above 1.5 = solid)
  • Leverage
    67D/E 0.65 (under 0.5 = conservative)
  • Efficiency
    21Asset Turnover 0.47x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +34.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin 10.9% · trend -5.9pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project ECVT's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -18.2%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$8.41
Total enterprise IV
$976M
Diluted shares
0.12B
Terminal PV
$688M (70% of total)
Year-5 FCF
$81M
YearProjected FCFDiscounted PV
+1$72M$65M
+2$74M$61M
+3$76M$57M
+4$79M$54M
+5$81M$50M
Terminal$1.11B$688M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$70M
investment in PP&E
Dividends paid (TTM)
cash returned to holders
Stock buybacks (TTM)
$42M
share count reduction
Stock-based comp (TTM)
$10M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.26B
everything owned
Total liabilities
$658M
everything owed
Stockholders' equity
$603M
shareholder claim
Net debt
$195M
LT debt minus cash

Recent performance · 40 quarters

Revenue↑+34.0% +$51M
$199M
Net Income↑+118.9% +$36M
$6M
Free Cash Flow↓-42.1% -$17M
$23M
Operating Margin↓-4.1pts
10.9%

Drill down